In addition, patient stratification is taking further shape with active research groups developing more reliable epigenetic mapping and multiplex biomarker panel approaches to substantiate biological endophenotypes such as BDNF hypermethylation that serve as biological hieroglyphics for cognitive decline or mood disorders. Here, BDNF is linked to mood disorder.